Recalls / Class II
Class IID-0098-2018
Product
Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
- Affected lot / code info
- Lot: #:16F649, Exp: May 2018
Why it was recalled
Failed Dissolution Specifications.
Recalling firm
- Firm
- Mayne Pharma Inc
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 1240 Sugg Pkwy, N/A, Greenville, North Carolina 27834-9006
Distribution
- Quantity
- 11,364 bottles
- Distribution pattern
- Nationwide within USA
Timeline
- Recall initiated
- 2017-11-09
- FDA classified
- 2017-11-29
- Posted by FDA
- 2017-12-06
- Terminated
- 2020-05-11
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0098-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.